selected publications
-
academic article
-
3377Ablation for atrial fibrillation with heart failure should be performed early a nationwide study.
European Heart Journal.
39.
2018
Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes – An observational follow-up study.
PLoS ONE.
13.
2018
Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria.
Diabetes Care.
41.
2018
SP418COLLAGEN TYPE III DEGRADATION IS ASSOCIATED WITH DETERIORATION OF KIDNEY FUNCTION IN PATIENTS WITH TYPE 2 DIABETES WITH MICROALBUMINURIA..
Nephrology,Dialysis and Transplantation.
33.
2018
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
Cardiovascular Diabetology.
17.
2018
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients.
Acta Diabetologica.
55.
2018
Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate.
European Journal of Preventive Cardiology.
24.
2017
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Cardiovascular Diabetology.
16.
2017
Toe–brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.
Diabetologia.
60.
2017
Is modification of the VVI backup mode in implantable cardioverter-defibrillators from St Jude medical required due to increased risk of inappropriate shocks?.
EP Europace.
19.
2016
Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria.
Journal of Diabetes and its Complications.
30.
2016
Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.
Diabetologia.
59.
2016
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
Cardiovascular Diabetology.
14.
2015
Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial.
PLoS ONE.
10.
2015
-
dataset
-
Clinical characteristics of the study population at baseline categorized according to growth differentiation factor 15 and fibroblast growth factor 23 below or above the median..
public-library-of-science.
2018
Stepwise Cox regression analyses: Biomarkers in relation to risk of fatal and nonfatal cardiovascular events, all-cause mortality and decline in eGFR >30% in 200 patients..
public-library-of-science.
2018
Baseline characteristics..
public-library-of-science.
2015
CRT_optimal_DRYAD.
dryad.
2015
Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial.
public-library-of-science.
2015
-
hide from search
-
Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
EP Europace.
2013
Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study.
public-library-of-science.
2008
Effect of metformin versus placebo on follow-up (intermediate and study visit) levels of HbA1c and insulin doses in 72 patients with type-1 diabetes during a one year period..
public-library-of-science.
2008
Inclusion, exclusion and withdrawal criteria.
public-library-of-science.
2008
Metabolism-related variables in 100 patients with type-1 diabetes before and after one year of treatment with metformin or placebo..
public-library-of-science.
2008
Non-hypoglycaemia-related serious adverse events in 100 patients with type-1 diabetes allocated treatment with metformin or placebo for one year..
public-library-of-science.
2008
Reported hypoglycaemic episodes in patients with type-1 diabetes during one year of treatment with metformin or placebo..
public-library-of-science.
2008
Subject characteristics at enrolment (−1 month) for 100 patients with type-1 diabetes..
public-library-of-science.
2008